Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed4
Terminated2

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT01257100Terminated
Environmental and Genetic Determinants of NPC
Herpesvirus 4, HumanNasopharyngeal Neoplasms
PrincipalinvestigatorStart date: 2010-12-08
NCT00342147Completed
Family Study of Head and Neck Cancers in Taiwan
Herpesvirus 4, HumanNasopharyngeal Neoplasms
PrincipalinvestigatorStart date: 1995-11-07
NCT01086709Completed
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Cervical NeoplasiaHPV Infections
Principalinvestigator
NCT01520272Completed
HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda
HPV16 Anitbody Levels Post VaccinationHPV18 Antibody Levels Post Vaccination
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jun Ma, M.D.

Sun Yat-sen University

Related
10 trials

Shared therapeutic areas:

Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Neoplasms
Similarity Score9%

Rachel L Winer, PhD, MPH

University of Washington

Related
8 trials

Shared therapeutic areas:

Cervical NeoplasiaHuman Papillomavirus Infection

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Ming-yuan Chen, MD, PhD

Sun Yat-sen University

Related
12 trials

Shared therapeutic areas:

Herpesvirus 4, HumanNasopharyngeal Neoplasms
Similarity Score9%

Rebecca Schnall, PhD, MPH

Columbia University

Related
7 trials

Shared therapeutic areas:

Human Papillomavirus Infection

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Paul Bloem, MSc

World Health Organization

Related
1 trials

Shared therapeutic areas:

Human Papillomavirus Infection
Similarity Score4%

Novartis Vaccines and Diagnostics

Novartis

Related
12 trials

Shared therapeutic areas:

Human Papillomavirus Infection
Similarity Score4%

Xiaozhong Chen, MD

Zhejiang Cancer Hospital

Related
7 trials

Shared therapeutic areas:

Nasopharyngeal Cancinoma (NPC)
Similarity Score4%

Sami L Gottlieb, PhD

World Health Organization

Related
1 trials

Shared therapeutic areas:

Human Papillomavirus Infection
Similarity Score4%

Jennifer Tang, MD

UNC Lineberger Comprehensive Cancer Center

Related
2 trials

Shared therapeutic areas:

Human Papillomavirus Infection

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Vikrant Sahasrabuddhe, MBBS, MPH, DrPH

Division of Cancer Prevention (DCP), NCI

Related
2 trials

Shared therapeutic areas:

Human Papillomavirus Infection

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT02586532PrincipalInvestigator

Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China

Nasopharyngeal Cancinoma (NPC)
Completed
NCT01257100PrincipalInvestigator

Environmental and Genetic Determinants of NPC

Herpesvirus 4, HumanNasopharyngeal Neoplasms
Terminated
NCT00393224PrincipalInvestigator

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms
Terminated
NCT00342147PrincipalInvestigator

Family Study of Head and Neck Cancers in Taiwan

Herpesvirus 4, HumanNasopharyngeal Neoplasms
Completed
NCT01086709PrincipalInvestigator

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

Cervical NeoplasiaHPV Infections
Completed
NCT01520272PrincipalInvestigator

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

HPV16 Anitbody Levels Post VaccinationHPV18 Antibody Levels Post Vaccination
Completed

All 6 trials loaded